🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

160 results for “Vertex Pharmaceuticals (Ireland) Limited” Clear

  1. PegInterferon

    Vertex Pharmaceuticals (Ireland) Limited

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  2. Placebo

    Vertex Pharmaceuticals (Ireland) Limited

    Pain

    phase 1 small molecule completed

    1 trial

  3. Povetacicept

    Vertex Pharmaceuticals (Ireland) Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  4. Prednisone

    Vertex Pharmaceuticals (Ireland) Limited

    Drug Interactions

    phase 1 small molecule completed

    1 trial

  5. SUZ

    Vertex Pharmaceuticals (Ireland) Limited

    Pain

    phase 1 small molecule completed

    1 trial

  6. Telaprevir

    Vertex Pharmaceuticals (Ireland) Limited

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  7. Telaprevir; Moxifloxacin; Placebo

    Vertex Pharmaceuticals (Ireland) Limited

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  8. Treatment sequence AB

    Vertex Pharmaceuticals (Ireland) Limited

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  9. VCH 916

    Vertex Pharmaceuticals (Ireland) Limited

    HCV Infection

    phase 1 small molecule completed

    1 trial

  10. VCH-222

    Vertex Pharmaceuticals (Ireland) Limited

    Hepatitis C

    phase 1 small molecule completed

    1 trial

  11. VX-118

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  12. VX-147

    Vertex Pharmaceuticals (Ireland) Limited

    Focal Segmental Glomerulosclerosis (FSGS)

    phase 1 small molecule completed

    1 trial

  13. VX-150

    Vertex Pharmaceuticals (Ireland) Limited

    Pain

    phase 1 small molecule completed

    1 trial

  14. VX-272

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    phase 1 small molecule active

    1 trial

  15. VX-433

    Vertex Pharmaceuticals (Ireland) Limited

    Narcolepsy Type 1 (NT1)

    phase 1 small molecule active

    1 trial

  16. VX-440

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  17. VX-509

    Vertex Pharmaceuticals (Ireland) Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  18. VX-548

    Vertex Pharmaceuticals (Ireland) Limited

    Pain

    phase 1 small molecule completed

    7 trials

  19. VX-581

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    phase 1 small molecule active

    1 trial

  20. VX-634

    Vertex Pharmaceuticals (Ireland) Limited

    Alpha 1-Antitrypsin Deficiency

    phase 1 small molecule completed

    1 trial

  21. VX-668

    Vertex Pharmaceuticals (Ireland) Limited

    Alpha-1 Antitrypsin Deficiency

    phase 1 small molecule completed

    1 trial

  22. VX-708

    Vertex Pharmaceuticals (Ireland) Limited

    Acute Pain

    phase 1 small molecule completed

    1 trial

  23. VX-708

    Vertex Pharmaceuticals (Ireland) Limited

    Pain

    phase 1 small molecule completed

    1 trial

  24. VX-770

    Vertex Pharmaceuticals (Ireland) Limited

    In Development for Cystic Fibrosis

    phase 1 small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources